Literature DB >> 18364393

Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease.

Bita Sahaf1, Kondala Atkuri, Kartoosh Heydari, Meena Malipatlolla, Jay Rappaport, Emmanuel Regulier, Leonard A Herzenberg, Leonore A Herzenberg.   

Abstract

Recombinant HIV-Tat (Tat) induces extensive apoptosis in peripheral blood mononuclear cells (PBMCs) cultured in typical CO2 incubators, which are equilibrated with air (21% O2). However, as we show here, Tat apoptosis induction fails in PBMCs cultured at physiological oxygen levels (5% O2). Under these conditions, Tat induces PBMCs to divide, efficiently primes them for HIV infection, and supports virus production by the infected cells. Furthermore, Tat takes only 2 h to prime PBMCs under these conditions. In contrast, PHA/IL-2, which is widely used to prime cells for HIV infection, takes 2-3 days. These findings strongly recommend culturing primary cells at physiological oxygen levels. In addition, they suggest HIV-Tat as a key regulator of HIV disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18364393      PMCID: PMC2278183          DOI: 10.1073/pnas.0712363105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

Authors:  O Prakash; Z Y Tang; Y E He; M S Ali; R Coleman; J Gill; G Farr; F Samaniego
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

2.  Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions.

Authors:  C C Caldwell; H Kojima; D Lukashev; J Armstrong; M Farber; S G Apasov; M V Sitkovsky
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Low oxygen tension and autologous plasma enhance T-cell proliferation and CD49d expression density in serum-free media.

Authors:  H Haddad; E T Papoutsakis
Journal:  Cytotherapy       Date:  2001       Impact factor: 5.414

4.  Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells.

Authors:  Jinseu Park; Jiyoon Ryu; Kyeong-Ae Kim; Hak Joo Lee; Jae Hoon Bahn; Kyuhyung Han; Eui Yul Choi; Kil Soo Lee; Hyeok Yil Kwon; Soo Young Choi
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

5.  Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines.

Authors:  D Zagury; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

6.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

Review 7.  TAT-mediated protein transduction into mammalian cells.

Authors:  M Becker-Hapak; S S McAllister; S F Dowdy
Journal:  Methods       Date:  2001-07       Impact factor: 3.608

8.  Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.

Authors:  A Ehret; M O Westendorp; I Herr; K M Debatin; J L Heeney; R Frank; P H Krammer
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals.

Authors:  P D Katsikis; M E García-Ojeda; E S Wunderlich; C A Smith; H Yagita; K Okumura; N Kayagaki; M Alderson; L A Herzenberg; L A Herzenberg
Journal:  Int Immunol       Date:  1996-08       Impact factor: 4.823

10.  Angiogenic properties of human immunodeficiency virus type 1 Tat protein.

Authors:  A Albini; G Barillari; R Benelli; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

View more
  16 in total

1.  Glut1-mediated glucose transport regulates HIV infection.

Authors:  Séverine Loisel-Meyer; Louise Swainson; Marco Craveiro; Leal Oburoglu; Cédric Mongellaz; Caroline Costa; Marion Martinez; François-Loic Cosset; Jean-Luc Battini; Leonard A Herzenberg; Leonore A Herzenberg; Kondala R Atkuri; Marc Sitbon; Sandrina Kinet; Els Verhoeyen; Naomi Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Our NIH years: a confluence of beginnings.

Authors:  Leonore A Herzenberg; Leonard A Herzenberg
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

3.  H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Authors:  Bita Sahaf; Yang Yang; Sally Arai; Leonard A Herzenberg; Leonore A Herzenberg; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation: HIV rebound with current ART appears to be due to infection with new endogenous founder virus and not to resurgence of pre-existing Tat-dependent viremia.

Authors:  Gideon Goldstein; Eve Damiano; Mardik Donikyan; Malika Pasha; Erik Beckwith; John Chicca
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

5.  Microfluidic platform for real-time signaling analysis of multiple single T cells in parallel.

Authors:  Shannon Faley; Kevin Seale; Jacob Hughey; David K Schaffer; Scott VanCompernolle; Brett McKinney; Franz Baudenbacher; Derya Unutmaz; John P Wikswo
Journal:  Lab Chip       Date:  2008-08-19       Impact factor: 6.799

6.  Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators.

Authors:  Amber T Washington; Gyanendra Singh; Ashok Aiyar
Journal:  Virol J       Date:  2010-05-10       Impact factor: 4.099

7.  Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Mol Syst Biol       Date:  2010-02-16       Impact factor: 11.429

8.  Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.

Authors:  Sharroya Charles; Tatyana Ammosova; Jessica Cardenas; Altreisha Foster; Jamie Rotimi; Marina Jerebtsova; Abisola A Ayodeji; Xiaomei Niu; Patricio E Ray; Victor R Gordeuk; Fatah Kashanchi; Sergei Nekhai
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

9.  Role of cellular iron and oxygen in the regulation of HIV-1 infection.

Authors:  Sergei Nekhai; Namita Kumari; Subhash Dhawan
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

10.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.